Published in Cell Host Microbe on October 08, 2014
Basal body multipotency and axonemal remodelling are two pathways to a 9+0 flagellum. Nat Commun (2015) 0.82
The more we know, the more we have to discover: an exciting future for understanding cilia and ciliopathies. Cilia (2015) 0.80
CD8+ T cells in Trypanosoma cruzi infection. Semin Immunopathol (2015) 0.80
Reaching for the Holy Grail: insights from infection/cure models on the prospects for vaccines for Trypanosoma cruzi infection. Mem Inst Oswaldo Cruz (2015) 0.76
The Cyclical Development of Trypanosoma vivax in the Tsetse Fly Involves an Asymmetric Division. Front Cell Infect Microbiol (2016) 0.75
Recombination-driven generation of the largest pathogen repository of antigen variants in the protozoan Trypanosoma cruzi. BMC Genomics (2016) 0.75
Long-Term Immunity to Trypanosoma cruzi in the Absence of Immunodominant trans-Sialidase-Specific CD8+ T Cells. Infect Immun (2016) 0.75
Lost but not forgotten. Cell Host Microbe (2014) 0.75
SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics (1999) 14.15
The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease. Science (2005) 7.61
Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection. J Virol (2001) 7.37
Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu Rev Immunol (1999) 7.18
Myocarditis. N Engl J Med (2000) 6.94
Biology of Trypanosoma cruzi. Annu Rev Microbiol (1973) 4.13
Susceptibility of beta 2-microglobulin-deficient mice to Trypanosoma cruzi infection. Nature (1992) 3.50
Modeling household transmission of American trypanosomiasis. Science (2001) 3.48
Memory CD8+ T cells provide innate immune protection against Listeria monocytogenes in the absence of cognate antigen. J Exp Med (2003) 3.20
Microtubule polarity and dynamics in the control of organelle positioning, segregation, and cytokinesis in the trypanosome cell cycle. J Cell Biol (1995) 2.85
The Trypanosoma cruzi proteome. Science (2005) 2.63
Parasite stage-specific recognition of endogenous Toxoplasma gondii-derived CD8+ T cell epitopes. J Infect Dis (2008) 2.40
Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data. Proc Natl Acad Sci U S A (2003) 2.38
Stage-specific surface antigens expressed during the morphogenesis of vertebrate forms of Trypanosoma cruzi. Exp Parasitol (1987) 2.25
Trypanosoma brucei spp. development in the tsetse fly: characterization of the post-mesocyclic stages in the foregut and proboscis. Parasitology (1999) 2.09
Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease. Nat Med (2008) 2.04
CD8+ T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes. PLoS Pathog (2006) 1.93
Nef interference with HIV-1-specific CTL antiviral activity is epitope specific. Blood (2006) 1.91
Rapid quantitation of Trypanosoma cruzi in host tissue by real-time PCR. Mol Biochem Parasitol (2003) 1.88
Parasite persistence correlates with disease severity and localization in chronic Chagas' disease. J Infect Dis (1999) 1.84
In vitro and in vivo high-throughput assays for the testing of anti-Trypanosoma cruzi compounds. PLoS Negl Trop Dis (2010) 1.72
Cell biology of Trypanosoma cruzi. Int Rev Cytol (1984) 1.68
The life cycle of Trypanosoma cruzi revisited. Int J Parasitol (2001) 1.58
Genetic evidence that an endosymbiont-derived endoplasmic reticulum-associated protein degradation (ERAD) system functions in import of apicoplast proteins. J Biol Chem (2009) 1.55
The heart of darkness: growth and form of Trypanosoma brucei in the tsetse fly. Trends Parasitol (2009) 1.54
Asymmetric cell division as a route to reduction in cell length and change in cell morphology in trypanosomes. Protist (2007) 1.43
Depletion of T-cell subpopulations results in exacerbation of myocarditis and parasitism in experimental Chagas' disease. Infect Immun (1994) 1.38
A new asymmetric division contributes to the continuous production of infective trypanosomes in the tsetse fly. Development (2012) 1.36
Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice. Vaccine (1998) 1.33
The paraflagellar rod of kinetoplastid parasites: from structure to components and function. Int J Parasitol (2009) 1.25
Flagellar morphogenesis: protein targeting and assembly in the paraflagellar rod of trypanosomes. Mol Cell Biol (1999) 1.23
Delivery by Trypanosoma cruzi of proteins into the MHC class I antigen processing and presentation pathway. J Immunol (1997) 1.20
The induction of Trypanosoma cruzi trypomastigote to amastigote transformation by low pH. Parasitology (1995) 1.19
Insufficient TLR activation contributes to the slow development of CD8+ T cell responses in Trypanosoma cruzi infection. J Immunol (2009) 1.17
Trypanosoma cruzi utilizes the host low density lipoprotein receptor in invasion. PLoS Negl Trop Dis (2011) 1.17
Integration of expression vectors into the ribosomal locus of Trypanosoma cruzi. Gene (2003) 1.16
Generation of CD8(+) T cell memory in response to low, high, and excessive levels of epitope. J Immunol (2002) 1.13
The paraflagellar rod of kinetoplastida: solved and unsolved questions. Parasitol Today (1996) 1.06
The ubiquitin-proteasome pathway plays an essential role in proteolysis during Trypanosoma cruzi remodeling. Biochemistry (2001) 1.05
CD8+ T cells specific for immunodominant trans-sialidase epitopes contribute to control of Trypanosoma cruzi infection but are not required for resistance. J Immunol (2010) 1.02
Genetic dissection of the Leishmania paraflagellar rod, a unique flagellar cytoskeleton structure. J Cell Sci (1999) 1.01
Humoral and cellular immune responses to Trypanosoma cruzi-derived paraflagellar rod proteins in patients with Chagas' disease. Infect Immun (2003) 0.98
Proteasome activity is required for the stage-specific transformation of a protozoan parasite. J Exp Med (1996) 0.97
Trypanosoma cruzi: protective immunity in mice immunized with paraflagellar rod proteins is associated with a T-helper type 1 response. Exp Parasitol (1996) 0.96
Immunization with recombinant paraflagellar rod protein induces protective immunity against Trypanosoma cruzi infection. Vaccine (2003) 0.96
Unravelling the kinetoplastid paraflagellar rod. Trends Cell Biol (1999) 0.94
Oral exposure to Trypanosoma cruzi elicits a systemic CD8⁺ T cell response and protection against heterotopic challenge. Infect Immun (2011) 0.94
Paraflagellar rod protein-specific CD8+ cytotoxic T lymphocytes target Trypanosoma cruzi-infected host cells. Parasite Immunol (2002) 0.92
Pure paraflagellar rod protein protects mice against Trypanosoma cruzi infection. Infect Immun (1995) 0.90
Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Trypanosoma cruzi infection: a vaccine candidate. Vaccine (2008) 0.87
Trypanosoma cruzi paraflagellar rod proteins 2 and 3 contain immunodominant CD8(+) T-cell epitopes that are recognized by cytotoxic T cells from Chagas disease patients. Mol Immunol (2012) 0.83
Protective immunogenicity of the paraflagellar rod protein 2 of Leishmania mexicana. Vaccine (2005) 0.83
Virus replication strategies and the critical CTL numbers required for the control of infection. PLoS Comput Biol (2011) 0.81